A dengue virus vaccine was recently developed not only to prevent first infections, but to avoid severe disease that may occur upon second and third infections. This consequence, called antibody dependent enhancement (ADE), now appears to be caused by the vaccine itself. Primary dengue virus infection may lead to a disease that includes fever, headache, … Continue reading A problem with dengue virus vaccine